| Identification | Back Directory | [Name]
4,7,11,14-Tetraazaoctacosanamide, N-[2-[bis(2-hydroxytetradecyl)amino]ethyl]-16-hydroxy-14-(2-hydroxytetradecyl)-4,7-bis[3-[[2-[(2-hydroxytetradecyl)amino]ethyl]amino]-3-oxopropyl]-10-oxo- | [CAS]
1510653-27-6 | [Synonyms]
G0-C14
4,7,11,14-Tetraazaoctacosanamide, N-[2-[bis(2-hydroxytetradecyl)amino]ethyl]-16-hydroxy-14-(2-hydroxytetradecyl)-4,7-bis[3-[[2-[(2-hydroxytetradecyl)amino]ethyl]amino]-3-oxopropyl]-10-oxo- | [Molecular Formula]
C106H216N10O10 | [MOL File]
1510653-27-6.mol | [Molecular Weight]
1790.91 |
| Chemical Properties | Back Directory | [Boiling point ]
1429.4±65.0 °C(Predicted) | [density ]
0.975±0.06 g/cm3(Predicted) | [form ]
Oil | [pka]
14.11±0.20(Predicted) | [color ]
Colorless to light yellow |
| Hazard Information | Back Directory | [Uses]
G0-C14 is a cationic lipid-like compound alkyl-modified polyamidoamine (PAMAM) dendrimer. G0-C14 involves in the preparation of a series of macrophage-targeted nanoparticles (NPs). NPs can be used for agent and vaccine delivery[1][2]. | [References]
[1] Li S, et al. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials. 2020 Mar;234:119760. DOI:10.1016/j.biomaterials.2020.119760
[2] Chen Q, et al. Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy. J Control Release. 2020 Jul 10;323:179-190. DOI:10.1016/j.jconrel.2020.03.044 |
|
| Company Name: |
yaoyangpharm
|
| Tel: |
17739007752 17324281842 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList1360066/0_EN.htm |
|